# Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis

> **NCT04785534** · NA · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 1000 (actual)

## Conditions studied

- Liver and Intrahepatic Bile Duct Carcinoma

## Interventions

- **OTHER:** Clinical Evaluation
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Liver Ultrasonographic Elastography
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT04785534
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-22
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785534, "Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04785534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*